Vismodegib: In Locally Advanced or Metastatic Basal Cell Carcinoma

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.11, 2012-07, pp. : 1535-1541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Hedgehog Pathway for Locally Advanced and Metastatic Basal Cell Carcinoma

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 655-659

Bentham Science Publishers

Access to resources Recommend Favorite

Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma

By Sfoungaristos Stavros Giannitsas Konstantinos Perimenis Petros

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. : 533-547

Informa Healthcare

Access to resources Recommend Favorite

Histologic Changes in Basal Cell Carcinoma After Treatment with Vismodegib

By Aldabagh Bishr Yu Justin Perkocha Luke A. Arron Sarah

Dermatologic Surgery, Vol. 39, Iss. 11, 2013-11 ,pp. : 1703-1705

Elsevier

Access to resources Recommend Favorite

Basal Cell Carcinoma Rebound After Cessation of Vismodegib in a Nevoid Basal Cell Carcinoma Syndrome Patient

By Wolfe Christopher M. Green W. Harris Cognetta Armand B. Hatfield H. Keith

Dermatologic Surgery, Vol. 38, Iss. 11, 2012-11 ,pp. : 1863-1866

Elsevier

Access to resources Recommend Favorite

Comment on Basal Cell Carcinoma Rebound After Cessation of Vismodegib in an Individual With Basal Cell Nevus Syndrome

By Ally Mina S. Wysong Ashley Tang Jean Y. Aasi Sumaira

Dermatologic Surgery, Vol. 39, Iss. 9, 2013-09 ,pp. : 1413-1414

Elsevier

Access to resources Recommend Favorite